| Literature DB >> 23199319 |
E Zonneveld-Huijssoon1, S Albani, B J Prakken, F van Wijk.
Abstract
Mucosal administration of an antigen eliciting bystander suppression at the site of inflammation results in effective antigen-specific immunotherapy for autoimmune diseases. Heat shock proteins are bystander antigens that are effective in peptide-specific immunotherapy in both experimental and human autoimmune disease. The efficacy of preventive peptide immunotherapy is increased by enhancing peptide-specific immune responses with proinflammatory agents. Combining peptide-specific immunotherapy with general suppression of inflammation may improve its therapeutic effect.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23199319 PMCID: PMC3530091 DOI: 10.1111/j.1365-2249.2012.04627.x
Source DB: PubMed Journal: Clin Exp Immunol ISSN: 0009-9104 Impact factor: 4.330